Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News NovaBay Pharmaceuticals Inc NBY

NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. It offers a portfolio of products for each step of the standard... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NYSEAM:NBY)

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Business Wire 21 hours ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Business Wire 8 days ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Business Wire November 7, 2024

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Business Wire November 6, 2024

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

Business Wire October 29, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, NBY, ARC on Behalf of Shareholders

PR Newswire September 23, 2024

Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm

PR Newswire September 23, 2024

NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.'s Avenova Brand and Business Is Fair to Shareholders

Business Wire September 20, 2024

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

PR Newswire September 20, 2024

Bullboard Posts (NYSEAM:NBY)

Acumen Health Holdings ("Acumen") to Acquire the Avenova bra

Breaking News: $NBY Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay PharmaceuticalsAcumen Health...
whytestocks - September 20, 2024

NovaBay Pharmaceuticals, Inc. (NBY): Laser-Focused on the Lu

http://beyondspx.com/2024/08/01/novabay-pharmaceuticals-inc-nby-laser-focused-on-the-lucrative-dry-eye-market/
MikeTester - August 1, 2024

Real stock price share value

5.25$
Nibinator - November 15, 2023

I m very conservative on that 150%

Looking for 300%
Nibinator - October 28, 2023

Who wants to make 150 % in 2 weeks

Me
Nibinator - October 28, 2023

15 november that will hit

0.85 easy
Nibinator - October 28, 2023